A new versatile transbronchial needle, the modified type 2B retractable needle, was used for the staging and diagnosis of bronchogenic carcinoma. It combines the advantages of its predecessors, the fixed type 1A needle and the retractable type 2A needle, such as convenience of usage and the added ability to sample peripheral as well as central lesions. The new modified type 2B retractable needle provides better protection of the airways and bronchoscope than the fixed type 1A needle and eliminates ransbronchial needle aspiration (TBNA) performed through the flexible fiberoptic bronchoscope has become an established procedure in the staging and diagnosis of bronchogenic carcinoma.1-12 Access to the mediastinum less invasively without the potential morbidity of mediastinoscopy and mediastinotomy has played a major role in the ever growing popularity of TBNA. In addition to the sampling of mediastinal sites, TBNA has also been shown to be efficacious in diagnosing peripheral pulmonary nodules and masses.5"1 Because of its broad applicability, we have placed considerable emphasis on improving TBNA in terms of its safety, yield, and ease of administration. 1988; 94:561-65) and the effect of these changes on diagnostic yield is examined. We conclude with recommendations regarding the selection of needles for TBNA for the staging and diagnosis of bronchogenic carcinoma.
A new versatile transbronchial needle, the modified type 2B retractable needle, was used for the staging and diagnosis of bronchogenic carcinoma. It combines the advantages of its predecessors, the fixed type 1A needle and the retractable type 2A needle, such as convenience of usage and the added ability to sample peripheral as well as central lesions. The new modified type 2B retractable needle provides better protection of the airways and bronchoscope than the fixed type 1A needle and eliminates ransbronchial needle aspiration (TBNA) performed through the flexible fiberoptic bronchoscope has become an established procedure in the staging and diagnosis of bronchogenic carcinoma. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Access to the mediastinum less invasively without the potential morbidity of mediastinoscopy and mediastinotomy has played a major role in the ever growing popularity of TBNA. In addition to the sampling of mediastinal sites, TBNA has also been shown to be efficacious in diagnosing peripheral pulmonary nodules and masses.5"1 Because of its broad applicability, we have placed considerable emphasis on improving TBNA in terms of its safety, yield, and ease of administration.
Traditionally, two transbronchial needles (Millrose, Mentor, Ohio) have been used for obtaining cytologic specimens. The type IA single lumen fixed needle is suited best for sampling central mediastinal nodes."2 The type 2A double lumen retractable needle can also be used for the diagnosis of peripheral nodules or masses.5" ' and the effect of these changes on diagnostic yield is examined. We conclude with recommendations regarding the selection of needles for TBNA for the staging and diagnosis of bronchogenic carcinoma.
MATERIAL AND METHODS Traditional Transbronchial Needles
The type IA single lumen fixed needle consists of a 1.3 cm long 22-gauge needle mounted on the tip of a 120 cm long flexible single lumen catheter. A metal guidewire with a rounded tip passes through the needle and protects the bronchoscope from laceration during passage through the channel. The guidewire provides some rigidity to the catheter. Once the site of aspiration is located, the guidewire is withdrawn into the needle and the bronchial wall is pierced. After penetration is achieved, the guidewire is further withdrawn into the catheter and suction is applied with a 20 ml syringe attached to a sideport at the proximal end of the catheter. The cytologic specimen is then flushed out of the catheter and needle with several milliliters of normal saline solution.
The type 2A double lumen retractable needle is composed of two flexible catheters and a removable metal guidewire. A 1.3 cm 22-gauge needle is mounted on the tip of the inner catheter and can be retracted into the outer catheter. At the distal end of the outer catheter is a smooth metal hub which provides maximum protection to the bronchoscope during passage through the channel. After the needle is advanced through the hub, the bronchus is pierced. The guidewire is then completely removed prior to aspiration of the specimen.
The advantages and disadvantages of the two traditional transbronchial needles are summarized in the first two columns of Table   Table 1 The type 2B modified double lumen retractable needle (Fig 1) has a design similar to the original type 2A needle described previously except that a small opening was created at the side of the needle and a side port was added at the proximal end of the outer catheter for suctioning (Fig 2) . This allows transmission of the negative suction pressure to the lumen between the inner and outer catheters. Since the lumen of the inner catheter is not used for suctioning, it is not necessary to remove or even retract the guidewire during aspiration. The guidewire, however, can still be partially retracted to increase the flexibility of the catheter when approaching peripheral lesions.
In the third column of Clinical trials were designed to determine the efficacy of the type 2B modified retractable needle when compared to the two traditional transbronchial needles. First, the type 2B needle was compared to the type IA single lumen fixed needle in ten consecutive patients at a total of 17 sites. Each of the two needles was used once to aspirate 13 mediastinal nodes (seven paratracheal, four carinal, two subcarinal), two hilar nodes, and two nodes at the right upper lobe spur. Next, the type 2B needle was compared to the original type 2A retractable needle in ten consecutive patients at 17 sites. Each of the two needles was used once to sample 14 mediastinal nodes (eight paratracheal, four carinal, two subearinal), one node at the right upper lobe spur, one right middle lobe nodule, and one right upper lobe anterior segment mass. In each pair of aspirations, the two needles were used in a random order. The slides were reviewed blindly by a single cytopathologist if the initial cytologic diagnosis for members of a pair differed.
The type 2B modified retractable needle was then compared to the type lB retractable needle, with its improved suction capability and to the type 3 retractable needle designed to prevent tissue plugging. Each of the three retractable needles was used once to The type 2B needle was compared to the type lB needle (improved suction capability) and the type 3 needle (designed to prevent tissue plugging) in 20 patients at 26 sites (Table 3 ; trial 3). Positive cytology was obtained by at least one of the three needles at 12 of the 26 sites. The individual yield (percentage of sites with positive cytology) of each needle was as follows: type IB, 46 percent; type 2B, 27 percent; type 3, 31 percent. Of note, at three sites, the only needle producing positive cytology was the type lB needle. The differences between the three needles were significant at p<0.05 (Cochran's Q statistic).
Further comparison of the type 2B needle and the type lB needle was made in 11 patients at 18 sites using more (two to three) aspirates per needle (Table  3 ; trial 4). Only 15 of the 18 sites were accessible to both needles, as three upper lobe lesions could not be reached by the type lB needle due to its lack of flexibility Positive cytology was detected at nine of the 15 sites with either of the two needles. The type lB and type 2B needles yielded malignant cytology in 53 percent and 60 percent ofcases, respectively There was no significant difference between the yield of these two needles when the likelihood of the sampling error was reduced by increasing the number of aspirates per needle.
Complications
In the 51 patients studied, there were no pneumothoraces or clinically significant hemorrhages resulting from TBNA with any of the five needles tested.
DISCUSSION
Transbronchial needle aspiration has been shown to be a valuable technique in the staging and diagnosis We discussed the flexibility of the type 2B needle and its importance in reaching peripheral lesions. Recently, it has also become clear that flexibility is also helpful in aspirating some central mediastinal nodes, specifically at the aortopulmonary (A-P) window. To sample deep into the A-P node, ideally the needle should be perpendicular to the bronchial wall when piercing it.3 This can be accomplished with the type 2B needle by retracting the guidewire to improve flexiblity of the catheter and extending the needle just beyond the tip of the flexed bronchoscope. The bronchoscope supports the needle during penetration of the wall. This technique could potentially improve the yield of TBNA at the A-P window
In conclusion, the type 2B retractable needle is a convenient, safe, and versatile transbronchial cytology needle. Its application should be beneficial to physicians using TBNA for the staging and diagnosis of bronchogenic carcinoma.
